Stay updated with breaking news from Nasdaq Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) from a hold rating to a buy rating in a report issued on Tuesday. Amneal Pharmaceuticals Stock Performance Shares of AMRX opened at $1.88 on Tuesday. Amneal Pharmaceuticals has a 12 month low of $1.24 and a 12 month high of $3.77. The company has […]
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Monday. Amneal Pharmaceuticals Stock Performance AMRX traded up $0.10 during trading on Monday, hitting $2.02. 751,600 shares of the stock traded hands, compared to its average volume […]
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) and Vaxxinity (NASDAQ:VAXX – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their risk, dividends, valuation, institutional ownership, profitability, earnings and analyst recommendations. Insider and Institutional Ownership 33.4% of Amneal Pharmaceuticals shares are […]
StockNews.com upgraded shares of Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Friday. NASDAQ:AMRX opened at $3.19 on Friday. The stock has a market capitalization of $966.31 million, a price-to-earnings ratio of 159.50, a PEG ratio of 0.16 and a beta […]
Amneal Pharmaceuticals (NASDAQ:AMRX – Get Rating) and Radius Health (NASDAQ:RDUS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations. Risk and Volatility Amneal Pharmaceuticals has a beta of […]